Loading patent…
AssigneeKorea Research Institute of Chemical Technology
InventorsNak Jeong KIM, Myung-Ae Bae, Sung-Eun Yoo, Namsook Kang, Jung Nyoung Heo, Kyu Yang Yi, Jee Hee Suh, Sung Youn Chang, Eun Sook Hwang, Jeong-Ho Hong
Estimating the term…
A phamaceutical composition comprising a phenyltetrazole derivative of formula (I) or a pharmaceutical acceptable salt thereof is effective in preventing or treating osteoporosis, obesity, diabetes, or hyperlipidemia, by regulating protein TAZ. wherein, A is ethyl or n-butyl; R1 is methyl, —CH2OH, —CO2CH3, —CH2F, —CH(OCH3)2, —CH2OC(═O)CH3, styryl or —CH2OCH2SCH3; R2 is H, Br, —CO2CH3, phenyl, pyridin-2-yl, pyridin-3-yl, or styryl; R3 is H or methyl; X is CH or N; and P is H or —CH(CH3)OCH2CH3.
A pharmaceutical composition for preventing or treating osteoporosis, comprising a compound of formula (I) or a pharmaceutical acceptable salt thereof as an active ingredient:
A pharmaceutical composition for preventing or treating obesity, diabetes, or hyperlipidemia, comprising a compound of formula (I) or a pharmaceutical acceptable salt thereof as an active ingredient:
Dependencies are inferred from the claim text.